OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based in Long Island, New York with facilities in Colorado, New Jersey and the United ...
Astellas will acquire OSI. Under the terms of the merger agreement, Astellas will increase its offer price to $57.50 per share, which represents a premium of ...
OSI Pharmaceuticals
Pharmaceutical company
OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. On Sunday, May 16, 2010 OSI agreed to be acquired by Japan-based, TSE-listed... Wikipedia
Parent organization: Astellas Pharma
Subsidiaries: Prosidion Limited, Oldtech Inc, OSI Eyetech, Inc, and more
Headquarters: Farmingdale, NY
Founded: 1983
People also ask
Who owns OSI Pharmaceuticals?
What drugs does Astellas sell?
What does Astellas Pharma do?
Is Astellas a biotech or pharma company?
OSI manufactures and sells TarcevaŽ (erlotinib), a leading cancer medication, and has several prospective new oncology medications in its R&D pipeline. OSI is ...
Oct 4, 2019 ˇ Opinions/Orders posted: OSI PHARMACEUTICALS, LLC v. APOTEX INC. [OPINION](pdf) Appeal Number: 18-1925 Origin: PTO Precedential
OSI Pharmaceuticals acquires oncology assets from Gilead Sciences. Gilead to focus on core expertise in infectious diseases.
On August 21, 2005, OSI Pharmaceuticals, Inc., a Delaware corporation (“OSI”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with ...
Jun 9, 2016 ˇ This settlement resolves allegations that OSI and Genentech promoted Tarceva (FDA-approved for second-line NSCLC) off-label by making false and misleading ...
Manufacturer and seller of cancer medicines. The company engages in discovering, developing and commercialization of molecular targeted therapies used in ...
Jun 6, 2016 ˇ Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC will pay $67 million to resolve False Claims Act allegations that they made misleading ...
Research outputs, collaborations and relationships for OSI Pharmaceuticals, Inc.